-
Joe Biden to Receive First Dose of Pfizer/BioNTech Vaccine on Monday
Post on 12/21/20
-
Better Coronavirus Stock: Pfizer vs. BioNTech
Post on 12/21/20
-
Here's Why Pfizer's Vaccine Is So Important
Post on 12/21/20
-
4 Reasons You Should Buy Pfizer Stock Right Now
Post on 12/21/20
-
Why Didn't Pfizer Stock Jump More After Winning Authorization for Its COVID Vaccine?
Post on 12/18/20
-
SCYNEXIS Prices of $85 Million Public Offering of Common Stock
Post on 12/17/20
-
Why AstraZeneca's and Sanofi's Bad News Could Be Great News for Pfizer and Moderna
Post on 12/17/20
-
What Pfizer's Vaccine Authorization Means for Moderna
Post on 12/17/20
-
3 Things Pfizer's Coronavirus Vaccine Still Has to Prove
Post on 12/17/20
-
SCYNEXIS Announces Launch of $50 Million Public Offering of Common Stock
Post on 12/16/20
-
Which Is the Best COVID Vaccine Stock Now: Pfizer, BioNTech, or Moderna?
Post on 12/16/20
-
AdaptHealth Prices $500M Senior Notes
Post on 12/15/20
-
Philly Scientists Were Just Awarded $37.6M to Develop a COVID-19 Antibody Treatment
Post on 12/15/20
-
Idera Pharmaceuticals Announces $5M In Further Proceeds from Private Placement of up to $20.7M
Post on 12/15/20
-
Eli Lilly to Acquire Prevail Therapeutics
Post on 12/15/20
-
When Will Pfizer and Moderna Recognize COVID Vaccine Revenue?
Post on 12/15/20
-
Here's Why Merck Made a Mistake by Selling Its Moderna Stake
Post on 12/15/20
-
Should the U.S. Have Bought More Doses of Pfizer's COVID Vaccine?
Post on 12/15/20
-
AdaptHealth Proposed Offering of $500 Million Senior Notes
Post on 12/14/20
-
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
Post on 12/14/20
-
Better Coronavirus Stock: Johnson & Johnson vs. Pfizer
Post on 12/14/20
-
FDA Authorizes Pfizer and BioNTech's Coronavirus Vaccine
Post on 12/14/20
-
Should Investors Buy Inovio for Its Coronavirus Vaccine?
Post on 12/14/20
-
3 Reasons to Buy Pfizer Stock Now
Post on 12/11/20
-
What Could Keep the FDA From Green Lighting Pfizer's and Moderna's Vaccines?
Post on 12/11/20
Philadelphia
